Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisle Langslet

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Atherosclerosis Plus|June 19, 2026
Retinal findings in familial hypercholesterolemia: An exploratory case-control studyGisle Langslet, Synne Kollstad, Øystein Kalsnes Jørstad, et al.
American Journal of Preventive Cardiology|July 11, 2025
Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway - A register studyGisle Langslet, Emil A Asprusten, Jannicke Igland, et al.
Diabetes & Vascular Disease Research|December 14, 2020
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>Gisle Langslet, Bernard Zinman, Christoph Wanner, et al.
Journal of Clinical Lipidology|December 22, 2015
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhoodGisle Langslet, Martin P Bogsrud, Ida Halvorsen, et al.
Scandinavian Cardiovascular Journal : SCJ|July 20, 2010
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled studyMartin Prøven Bogsrud, Leiv Ose, Gisle Langslet, et al.
Atherosclerosis|March 8, 2011
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemiaMarit S Nenseter, Henriette Walaas Lindvig, Thor Ueland, et al.
American Journal of Preventive Cardiology|July 30, 2021
Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issuesGisle Langslet, Anja K Johansen, Martin P Bogsrud, et al.
Cardiovascular Drugs and Therapy|May 5, 2020
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension StudyGisle Langslet, G Kees Hovingh, John R Guyton, et al.
The Journal of Pediatrics|June 11, 2015
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular RiskMarjet J A M Braamskamp, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Clinical Lipidology|February 20, 2021
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosisAnja K Johansen, Martin P Bogsrud, Jeanine Roeters van Lennep, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Atherosclerosis Plus|June 19, 2026
Retinal findings in familial hypercholesterolemia: An exploratory case-control studyGisle Langslet, Synne Kollstad, Øystein Kalsnes Jørstad, et al.
American Journal of Preventive Cardiology|July 11, 2025
Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway - A register studyGisle Langslet, Emil A Asprusten, Jannicke Igland, et al.
Diabetes & Vascular Disease Research|December 14, 2020
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>Gisle Langslet, Bernard Zinman, Christoph Wanner, et al.
Journal of Clinical Lipidology|December 22, 2015
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhoodGisle Langslet, Martin P Bogsrud, Ida Halvorsen, et al.
Scandinavian Cardiovascular Journal : SCJ|July 20, 2010
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled studyMartin Prøven Bogsrud, Leiv Ose, Gisle Langslet, et al.
Atherosclerosis|March 8, 2011
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemiaMarit S Nenseter, Henriette Walaas Lindvig, Thor Ueland, et al.
American Journal of Preventive Cardiology|July 30, 2021
Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issuesGisle Langslet, Anja K Johansen, Martin P Bogsrud, et al.
Cardiovascular Drugs and Therapy|May 5, 2020
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension StudyGisle Langslet, G Kees Hovingh, John R Guyton, et al.
The Journal of Pediatrics|June 11, 2015
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular RiskMarjet J A M Braamskamp, Claudia Stefanutti, Gisle Langslet, et al.
Journal of Clinical Lipidology|February 20, 2021
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosisAnja K Johansen, Martin P Bogsrud, Jeanine Roeters van Lennep, et al.
Pageof 6